![Dong Lyu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dong Lyu
Corporate Officer/Principal presso
Zhuhai Hillhouse Investment Management Holding Co. Ltd.
Profilo
Dong Lyu currently works at Zhuhai Hillhouse Investment Management Holding Co. Ltd., as Managing Director from 2020 and Zhuhai Gao Ling Equity Investment Management Co. Ltd., as Managing Director from 2020.
Dr. Lyu also formerly worked at Genor Biopharma Holdings Ltd., as Non-Executive Director from 2021 to 2025, Shanghai Ark Biopharmaceutical Co., Ltd., as Director in 2021, Keymed Biosciences, Inc., as Non-Executive Director from 2021 to 2022, Jacobio Pharmaceuticals Group Co., Ltd., as Non-Executive Director from 2020 to 2023, Clover Biopharmaceuticals Ltd., as Non-Executive Director from 2021 to 2022, Pag Growth Zhuhai Holding Investment Management Co. Ltd., as Managing Director from 2016 to 2020, Luye Pharma Group Ltd., as Non-Executive Director from 2023 to 2025, and Shanghai Panxin Equity Investment Management Co. Ltd., as VP- Pharmaceutical & Medical Device Investment from 2011 to 2016.
Dr. Lyu received his graduate degree in 2003 from Peking University, doctorate degree in 2010 from China Pharmaceutical University, and undergraduate degree in 1996 from Beijing Medical University.
Posizioni attive di Dong Lyu
| Società | Posizione | Inizio |
|---|---|---|
Zhuhai Hillhouse Investment Management Holding Co. Ltd. | Corporate Officer/Principal | 30/09/2020 |
Zhuhai Gao Ling Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 01/09/2020 |
Precedenti posizioni note di Dong Lyu
| Società | Posizione | Fine |
|---|---|---|
| EDDING GENOR GROUP HOLDINGS LIMITED | Direttore/Membro del Consiglio | 26/06/2025 |
| LUYE PHARMA GROUP LTD. | Direttore/Membro del Consiglio | 10/03/2025 |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Direttore/Membro del Consiglio | 31/08/2023 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Direttore/Membro del Consiglio | 28/10/2022 |
| KEYMED BIOSCIENCES INC. | Direttore/Membro del Consiglio | 29/03/2022 |
Formazione di Dong Lyu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
97
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Luye Pharma Group Ltd.
 Luye Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
China Pharmaceutical University
 China Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Medical University
 Beijing Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Health Technology |
Shanghai Panxin Equity Investment Management Co. Ltd. | |
Genor Biopharma Holdings Ltd.
 Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs | Health Technology |
Keymed Biosciences, Inc.
 Keymed Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the treatment of asthma, chronic obstructive pulmonary and other respiratory diseases | Health Technology |
Jacobio Pharmaceuticals Group Co., Ltd.
 Jacobio Pharmaceuticals Group Co., Ltd. BiotechnologyHealth Technology Engages in research and development of drugs | Health Technology |
Clover Biopharmaceuticals Ltd.
 Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Pag Growth Zhuhai Holding Investment Management Co. Ltd. | |
Zhuhai Hillhouse Investment Management Holding Co. Ltd. | |
Zhuhai Gao Ling Equity Investment Management Co. Ltd. |
